Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

Not Applicable

Withdrawn

Conditions: Bipolar Disorder
Schizophrenia

Interventions: Other: Placebo
Dietary Supplement: Green Tea

First Posted Date: 2009-07-08

Last Posted Date: 2018-07-18

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00934908

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass

Not Applicable

Completed

Conditions: Congenital Heart Disease
Disorder of Fetus or Newborn

Interventions: Drug: methylprednisolone (IVMP)
Drug: methylprednisolone (two doses IVMP)

First Posted Date: 2009-07-08

Last Posted Date: 2011-12-09

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 77

Registration Number: NCT00934843

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Accuracy of the Galilei Analyzer to Calculate the Effective Corneal Power After Corneal Refractive Surgery

Not Applicable

Terminated

Conditions: Cataracts

Interventions: Device: Galilei dual Scheimpflug analyzer

First Posted Date: 2009-07-08

Last Posted Date: 2018-07-23

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 7

Registration Number: NCT00934804

Locations: 🇺🇸
Helga Sandoval, MD, Charleston, South Carolina, United States

Multifocals and Accommodating/Bilateral Implantation of Different Multifocal Intraocular Lens (IOLs)

Terminated

Conditions: Cataracts

First Posted Date: 2009-07-08

Last Posted Date: 2009-11-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 9

Registration Number: NCT00934960

Locations: 🇺🇸
Helga Sandoval, MD, Charleston, South Carolina, United States

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Phase 4

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Naltrexone 50 Mg
Drug: Placebo

First Posted Date: 2009-06-15

Last Posted Date: 2018-07-10

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 358

Registration Number: NCT00920829

Locations: 🇺🇸
Medical University of South Carolin, Charleston, South Carolina, United States
🇺🇸
Medical University of South Carolina, Center for Drug and Alcohol Programs, Charleston, South Carolina, United States

Alendronate in Juvenile Osteoporosis

Completed

Conditions: Juvenile Osteoporosis
Low Bone Density
Fractures

Interventions: Drug: Alendronate (Fosamax)

First Posted Date: 2009-06-15

Last Posted Date: 2018-07-11

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 11

Registration Number: NCT00920075

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

Not Applicable

Completed

Conditions: Liver Failure

Interventions: Drug: Vasopressin
Drug: Normal saline placebo

First Posted Date: 2009-04-22

Last Posted Date: 2018-10-17

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 18

Registration Number: NCT00886262

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting

Not Applicable

Completed

Conditions: Obesity, Morbid
Postoperative Nausea and Vomiting
Postoperative Pain

Interventions: Drug: Gabapentin
Drug: Placebo

First Posted Date: 2009-04-22

Last Posted Date: 2018-09-20

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 62

Registration Number: NCT00886236

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Depth of Focus Comparison Between Acrysof IQ and Acrysof Natural IOLs

Withdrawn

Conditions: Vision
Cataract

First Posted Date: 2009-04-22

Last Posted Date: 2018-06-07

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00886249

Locations: 🇺🇸
Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina, United States

Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Phase 2

Completed

Conditions: Liver Cancer

Interventions: Biological: bevacizumab
Drug: sorafenib tosylate
Drug: erlotinib hydrochloride

First Posted Date: 2009-04-15

Last Posted Date: 2017-09-11

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 95

Registration Number: NCT00881751

Locations: 🇺🇸
UVA Cancer Center, Charlottesville, Virginia, United States
🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸
Tennessee Oncology, PLLCat Sarah Cannon Cancer Center, Nashville, Tennessee, United States

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy